logo

Zafgen, Inc (ZFGN)



Trade ZFGN now with
  Date
  Headline
9/5/2019 7:12:19 AM Zafgen Plans To Explore Strategic Options
8/12/2019 7:52:50 AM Wedbush Is Cutting Zafgen, Inc (ZFGN) FY20 Estimate To -0.96 From -0.88
8/12/2019 7:52:36 AM Wedbush Is Cutting Zafgen, Inc (ZFGN) Q4 20 Estimate To -0.24 From -0.22
8/12/2019 7:51:54 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q3 20 Estimate To -0.25 From -0.23
8/12/2019 7:51:34 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q2 20 Estimate To -0.24 From -0.22
8/12/2019 7:51:23 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q1 20 Estimate To -0.24 From -0.22
8/12/2019 7:51:00 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) FY19 Estimate To -1.22 From -1.12
8/12/2019 7:50:46 AM Wedbush Is Cutting Zafgen, Inc (ZFGN) Q4 19 Estimate To -0.26 From -0.23
8/12/2019 7:50:27 AM Wedbush Is Lowering Zafgen, Inc (ZFGN) Q3 19 Estimate To -0.29 From -0.25
8/12/2019 7:49:35 AM Wedbush Reiterates Zafgen, Inc (ZFGN) At Outperform With $6 Price Target
5/30/2019 7:04:55 AM Zafgen Reports Receipt Of Minutes From Type A Meeting With FDA
1/17/2019 7:03:54 AM Zafgen Announces Positive Data For Second Cohort Of Its Phase 2 Clinical Trial Of ZGN-1061
11/26/2018 7:03:42 AM Zafgen Provides Update On Investigational New Drug Application For ZGN-1061
8/8/2018 8:54:47 AM Wedbush Is Increasing Zafgen, Inc (ZFGN) FY19 Estimate To -1.82 From -1.97
8/8/2018 8:54:30 AM Wedbush Is Increasing Zafgen, Inc (ZFGN) FY18 Estimate To -1.99 From -2.09